Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 22:13:608001.
doi: 10.3389/fnmol.2020.608001. eCollection 2020.

NPY and Gene Therapy for Epilepsy: How, When,... and Y

Affiliations
Review

NPY and Gene Therapy for Epilepsy: How, When,... and Y

Stefano Cattaneo et al. Front Mol Neurosci. .

Abstract

Neuropeptide Y (NPY) is a neuropeptide abundantly expressed in the mammalian central and peripheral nervous system. NPY is a pleiotropic molecule, which influences cell proliferation, cardiovascular and metabolic function, pain and neuronal excitability. In the central nervous system, NPY acts as a neuromodulator, affecting pathways that range from cellular (excitability, neurogenesis) to circuit level (food intake, stress response, pain perception). NPY has a broad repertoire of receptor subtypes, each activating specific signaling pathways in different tissues and cellular sub-regions. In the context of epilepsy, NPY is thought to act as an endogenous anticonvulsant that performs its action through Y2 and Y5 receptors. In fact, its overexpression in the brain with the aid of viral vectors can suppress seizures in animal models of epilepsy. Therefore, NPY-based gene therapy may represent a novel approach for the treatment of epilepsy patients, particularly for pharmaco-resistant and genetic forms of the disease. Nonetheless, considering all the aforementioned aspects of NPY signaling, the study of possible NPY applications as a therapeutic molecule is not devoid of critical aspects. The present review will summarize data related to NPY biology, focusing on its anti-epileptic effects, with a critical appraisal of key elements that could be exploited to improve the already existing NPY-based gene therapy approaches for epilepsy.

Keywords: NPY; Y2 receptor; epilepsy; gene therapy; viral vectors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Neuropeptide Y processing and its potential role in the epileptic hippocampal network. (A) Schematic representation of NPY intracellular processing and extracellular metabolism. (B) Illustration of hippocampal formation rearrangements after an epileptic insult. Red dots represent synapses newly formed by the mossy fiber sprouting in the inner molecular layer that contain NPY and pre-synaptic Y2 receptors. DG, dentate gyrus; CA3/CA1, Cornu Ammonis; OML, outer molecular layer; IML, inner molecular layer; GCL, granule cell layer.

References

    1. Abid K., Rochat B., Lassahn P. G., Stöcklin R., Michalet S., Brakch N., et al. (2009). Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35. A new peptide generated by plasma kallikrein. J. Biol. Chem. 284, 24715–24724. 10.1074/jbc.M109.035253 - DOI - PMC - PubMed
    1. Aicher S. A., Springston M., Berger S. B., Reis D. J., Wahlestedt C. (1991). Receptor-selective analogs demonstrate NPY/PYY receptor heterogeneity in rat brain. Neurosci. Lett. 130, 32–36. 10.1016/0304-3940(91)90220-N - DOI - PubMed
    1. Allen J., Novotny J., Martin J., Heinrich G. (1987). Molecular structure of mammalian neuropeptide Y: analysis by molecular cloning and computer-aided comparison with crystal structure of avian homologue. Proc. Natl. Acad. Sci. U. S. A. 84, 2532–2536. 10.1073/pnas.84.8.2532 - DOI - PMC - PubMed
    1. Atanasova K. R., Reznikov L. R. (2018). Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis. Respir. Res. 19:149. 10.1186/s12931-018-0846-4 - DOI - PMC - PubMed
    1. Baldock P. A., Allison S. J., Lundberg P., Lee N. J., Slack K., Lin E. J. D., et al. (2007). Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J. Biol. Chem. 282, 19092–19102. 10.1074/jbc.M700644200 - DOI - PubMed

LinkOut - more resources